Cargando…
Dendrimer size effects on the selective brain tumor targeting in orthotopic tumor models upon systemic administration
Malignant gliomas are the most common and aggressive form of primary brain tumors, with a median survival of 15–20 months for patients receiving maximal interventions. Advances in nanomedicine have provided tumor‐specific delivery of chemotherapeutics to potentially overcome their off‐target toxicit...
Autores principales: | Liaw, Kevin, Zhang, Fan, Mangraviti, Antonella, Kannan, Sujatha, Tyler, Betty, Kannan, Rangaramanujam M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237147/ https://www.ncbi.nlm.nih.gov/pubmed/32440565 http://dx.doi.org/10.1002/btm2.10160 |
Ejemplares similares
-
Targeted systemic dendrimer delivery of CSF‐1R inhibitor to tumor‐associated macrophages improves outcomes in orthotopic glioblastoma
por: Liaw, Kevin, et al.
Publicado: (2020) -
Targeting Mitochondrial Dysfunction and Oxidative Stress in Activated Microglia using Dendrimer-Based Therapeutics
por: Sharma, Anjali, et al.
Publicado: (2018) -
Microglial migration and interactions with dendrimer nanoparticles are altered in the presence of neuroinflammation
por: Zhang, Fan, et al.
Publicado: (2016) -
Dense hydroxyl polyethylene glycol dendrimer targets activated glia in multiple CNS disorders
por: Sharma, Anjali, et al.
Publicado: (2020) -
Systemic administration of dendrimer N‐acetyl cysteine improves outcomes and survival following cardiac arrest
por: Modi, Hiren R., et al.
Publicado: (2021)